Legend Biotech Corporation LEGN
$ 34.06
0.12%
Annual report 2023
added 12-14-2024
Legend Biotech Corporation Balance Sheet 2011-2024 | LEGN
Annual Balance Sheet Legend Biotech Corporation
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -206 M | - | - | - | - | - | - | - | ||
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
3.18 M | 3.56 M | 911 K | 1.46 M | 1.03 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 280 M | 283 M | 261 M | - | - | - | - | - | - | - |
Total Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
597 M | 587 M | 354 M | 124 M | 411 M | 420 M | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | 55.3 M | 46.3 M | 40.3 M | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
1.85 B | 1.33 B | 1.12 B | 722 M | 288 M | 429 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
1.28 B | 786 M | 689 M | 456 M | 83.4 M | 210 M | - | - | - | - | - | - | - |
Book Value |
1.25 B | 744 M | 766 M | 598 M | -123 M | 8.65 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | 280 M | -123 M | 8.65 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Legend Biotech Corporation
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | 1.59 M | - | 1.62 M | - | 1.91 M | - | - | - | 5.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 367 M | - | 274 M | - | 280 M | - | - | - | 283 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | 647 M | - | 535 M | - | 441 M | - | - | - | 411 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | 471 M | - | 340 M | - | 280 M | - | 401 M | - | -123 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | - | 1.12 B | - | 875 M | - | 721 M | - | - | - | 288 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | - | 689 M | - | 488 M | - | 456 M | - | 562 M | - | 83.4 M | - | - | - | 210 M | - | - | - | 2.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | - | 471 M | - | 340 M | - | 280 M | - | - | - | -123 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | - | 471 M | - | 340 M | - | 280 M | - | 401 M | - | -123 M | - | - | - | 8.65 M | - | - | - | 12.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency